Guidelines for diagnosis and management of childhood epilepsy.
BACKGROUND
Seizures constitute the most common neurological problem in children and the majority of epilepsy has its onset in childhood. Appropriate diagnosis and management of childhood epilepsy is essential to improve quality of life in these children. Evidence-based clinical practice guidelines, modified to the Indian setting by a panel of experts, are not available.


METHODS
The Indian Academy of Pediatrics organized a consensus meeting on the diagnosis and management of childhood epilepsy on 22-23 of July 2006 at Mumbai. An expert committee was formed consisting of pediatricians,pediatric epileptologists, pediatric and adult neurologists, electrophysiologists, neuroradiologists, neurosurgeons and intensivists. A consensus was reached during the discussion that followed presentation by each of these experts. The process of updating these recommendations and arriving at consensus continued till 2009.


OBJECTIVE
To develop practice guidelines for diagnosis and management of childhood epilepsy.


CONCLUSIONS
Recommendations for diagnosis and management of following childhood seizures and epilepsies are given: neonatal seizures, acute symptomatic seizures, neurocysticercosis, febrile seizures, idiopathic partial and generalized epilepsies, first unprovoked seizure, newly diagnosed epilepsy, catastrophic epilepsies of infancy, refractory epilepsies of older children and adolescents, epilepsy with cognitive deterioration and status epilepticus.
D000465:Algorithms; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D004827:Epilepsy / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D007194:India; D007223:Infant; D007231:Infant, Newborn; D008140:Lorazepam / Q000627:therapeutic use; D008874:Midazolam / Q000627:therapeutic use; D010372:Pediatrics / Q000379:methods*; D010672:Phenytoin / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use
D000927:Anticonvulsants; D010672:Phenytoin; D011736:Pyridoxine; D008140:Lorazepam; D003975:Diazepam; D008874:Midazolam